Ongoing Studies

MedaPhase is evaluating the safety and effectiveness of a systemic investigational medication for the treatment of Atopic Dermatitis (Eczema)

You may be qualified to participate if you:

• Are 18 years of age or older
• Have at least 10% body surface area affected by Atopic Dermatitis
• Are willing to follow a treatment plan of scheduled study visits, lab tests, and other study procedures for the duration of the study.

For participants, all investigational medication (or inactive placebo), study-related tests, and study doctor’s visits will be provided at no cost for the duration of the study.  Participation is voluntary and you may withdraw at any time.

MedaPhase is evaluating the safety and effectiveness of a topical  investigational medication, or placebo, for the treatment of Molluscum Contagiosum.

Your child may be qualified to participate if they:

• Are 2-17 years of age
• Have at least 3 but no more than 40 Molluscum Contagiosum on the face, trunk, or extremities.
• Are willing to follow a treatment plan of scheduled study visits, lab tests, and other study procedures for the duration of the study

For participants, all investigational medication (or inactive placebo), study-related tests, and study doctor’s visits will be provided at no cost for the duration of the study.  Participation is voluntary and you may withdraw at any time.